Sotera Health Reports Third-Quarter and Year-to-Date 2023 Re

01.11.2023 - Q3 2023 net revenues of $263 million increased 6%, compared to Q3 2022Q3 2023 net loss of $14 million or $0.05 per diluted share, compared to net income of $25 million or $0.09 per diluted share in Q3 2022 Q3 2023 Adjusted EBITDA of $134 million ...

Related Keywords

Russia , Illinois , United States , Delaware , United Kingdom , Georgia , New Mexico , Canada , Willowbrook , Canadian , Kristin Gibbs , Jason Peterson , Michaelb Petras Jr , Sotera Health Company , Sotera Health , Wolfe Research Conference , Presentation Events Sotera Health , Investor Relations Sotera Health , Global Health , Regulatory Compliance Associates Inc , United Kingdom Or European Union , Chief Executive Officer , Safeguarding Global Health , Nelson Labs , Adjusted Net Income , Net Leverage Ratio , Note Regarding Forward Looking Statements , Investor Relations , Research Conference , European Union , Net Debt , Adjusted Net , Health Company , Safeguarding Global , Marketing Officer , Bioscience Labs , Medical Isotopes , Settlement Agreements , Settling Defendants , Consolidated Statements , Regulatory Compliance Associates , Months Ended September , Represents Adjusted , Months Ended December , Sotera Health Company Chart , Otera Health Company Kurs , Otera Health Company Aktie ,